Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1909 1
1924 1
1925 1
1937 1
1947 1
1953 2
1958 1
1959 1
1961 1
1963 1
1964 2
1968 1
1970 1
1974 1
1975 3
1976 5
1977 4
1978 6
1979 5
1980 2
1981 2
1982 2
1983 6
1984 9
1985 8
1986 4
1987 11
1988 9
1989 17
1990 18
1991 17
1992 15
1993 22
1994 22
1995 29
1996 33
1997 61
1998 45
1999 48
2000 56
2001 54
2002 42
2003 61
2004 72
2005 62
2006 71
2007 87
2008 70
2009 74
2010 77
2011 107
2012 111
2013 128
2014 121
2015 135
2016 144
2017 165
2018 161
2019 196
2020 214
2021 240
2022 94
Text availability
Article attribute
Article type
Publication date

Search Results

2,643 results
Results by year
Filters applied: . Clear all
Page 1
Hair Loss: Common Causes and Treatment.
Phillips TG, Slomiany WP, Allison R. Phillips TG, et al. Am Fam Physician. 2017 Sep 15;96(6):371-378. Am Fam Physician. 2017. PMID: 28925637 Free article.
Hair loss is often distressing and can have a significant effect on the patient's quality of life. ...Alopecia areata is diagnosed by typical patches of hair loss and is self-limited. ...
Hair loss is often distressing and can have a significant effect on the patient's quality of life. ...Alopecia a
Common questions and misconceptions about creatine supplementation: what does the scientific evidence really show?
Antonio J, Candow DG, Forbes SC, Gualano B, Jagim AR, Kreider RB, Rawson ES, Smith-Ryan AE, VanDusseldorp TA, Willoughby DS, Ziegenfuss TN. Antonio J, et al. J Int Soc Sports Nutr. 2021 Feb 8;18(1):13. doi: 10.1186/s12970-021-00412-w. J Int Soc Sports Nutr. 2021. PMID: 33557850 Free PMC article. Review.
Does creatine cause kidney damage/renal dysfunction? 4. Does creatine cause hair loss / baldness? 5. Does creatine lead to dehydration and muscle cramping? ...
Does creatine cause kidney damage/renal dysfunction? 4. Does creatine cause hair loss / baldness? 5. Does creatine lead to deh …
Hair Loss Myths.
DiMarco G, McMichael A. DiMarco G, et al. J Drugs Dermatol. 2017 Jul 1;16(7):690-694. J Drugs Dermatol. 2017. PMID: 28697221 Review.

INTRODUCTION: Hair loss is a common complaint seen in dermatology clinics. From frustration and attempts at self-help, patients with hair loss may present to the dermatologist with false beliefs, or myths, about the causes of their condition a …

INTRODUCTION: Hair loss is a common complaint seen in dermatology clinics. From frustration and attempts at self-help …

Microneedling for the treatment of hair loss?
Fertig RM, Gamret AC, Cervantes J, Tosti A. Fertig RM, et al. J Eur Acad Dermatol Venereol. 2018 Apr;32(4):564-569. doi: 10.1111/jdv.14722. Epub 2017 Dec 21. J Eur Acad Dermatol Venereol. 2018. PMID: 29194786 Review.
This therapy is used to induce collagen formation, neovascularization and growth factor production of treated areas. It has been used in a wide range of dermatologic conditions, including androgenetic alopecia (AGA) and alopecia areata, among others. While th …
This therapy is used to induce collagen formation, neovascularization and growth factor production of treated areas. It has been used …
Medicinal Plants for the Treatment of Hair Loss and the Suggested Mechanisms.
Shen YL, Li XQ, Pan RR, Yue W, Zhang LJ, Zhang H. Shen YL, et al. Curr Pharm Des. 2018;24(26):3090-3100. doi: 10.2174/1381612824666180911114810. Curr Pharm Des. 2018. PMID: 30205796 Review.
Androgenic alopecia (AGA) is the most common type of hair loss, which affects a great number of both men and women. Alopecia can be treated with various hair loss strategies, including hair transplant, cosmetics and medication. ...
Androgenic alopecia (AGA) is the most common type of hair loss, which affects a great number of both men and women. …
Targeting Wnt/β-Catenin Pathway for Developing Therapies for Hair Loss.
Choi BY. Choi BY. Int J Mol Sci. 2020 Jul 12;21(14):4915. doi: 10.3390/ijms21144915. Int J Mol Sci. 2020. PMID: 32664659 Free PMC article. Review.
Persistent hair loss is a major cause of psychological distress and compromised quality of life in millions of people worldwide. Remarkable progress has been made in understanding the molecular basis of hair loss and identifying valid intracellular tar …
Persistent hair loss is a major cause of psychological distress and compromised quality of life in millions of people worldwid …
Androgenetic alopecia: an evidence-based treatment update.
Varothai S, Bergfeld WF. Varothai S, et al. Am J Clin Dermatol. 2014 Jul;15(3):217-30. doi: 10.1007/s40257-014-0077-5. Am J Clin Dermatol. 2014. PMID: 24848508 Review.
It is characterized by progressive hair loss, especially of scalp hair, and has distinctive patterns of loss in women versus men, but in both genders the central scalp is most severely affected. ...In addition to the scarce pharmacologic treatments, th …
It is characterized by progressive hair loss, especially of scalp hair, and has distinctive patterns of loss in …
Hair Loss.
Imhof RL, Davis DMR, Tollefson MM. Imhof RL, et al. Pediatr Rev. 2020 Nov;41(11):570-584. doi: 10.1542/pir.2019-0009. Pediatr Rev. 2020. PMID: 33139410 No abstract available.
A proprietary herbal extract against hair loss in androgenetic alopecia and telogen effluvium: a placebo-controlled, single-blind, clinical-instrumental study.
Pekmezci E, Dündar C, Türkoğlu M. Pekmezci E, et al. Acta Dermatovenerol Alp Pannonica Adriat. 2018 Jun;27(2):51-57. Acta Dermatovenerol Alp Pannonica Adriat. 2018. PMID: 29945259 Free article. Clinical Trial.
INTRODUCTION: Currently there are only a limited number of drugs available for treatment of androgenetic alopecia and telogen effluvium. However, certain plants and their standardized extracts may provide some clinical benefits against hair loss. ...In combin …
INTRODUCTION: Currently there are only a limited number of drugs available for treatment of androgenetic alopecia and telogen effluvi …
Spironolactone in dermatology: uses in acne and beyond.
Searle TN, Al-Niaimi F, Ali FR. Searle TN, et al. Clin Exp Dermatol. 2020 Dec;45(8):986-993. doi: 10.1111/ced.14340. Epub 2020 Aug 26. Clin Exp Dermatol. 2020. PMID: 32844462 Review.
Its antiandrogenic properties make it suitable for diseases in which excess androgen production results in unwanted and psychologically distressing manifestations in susceptible females. Treatment with spironolactone aims to attenuate androgen-mediated conditions including …
Its antiandrogenic properties make it suitable for diseases in which excess androgen production results in unwanted and psychological …
2,643 results